KalshiVerfügbarkeit prüfenKYC erforderlich2% GebührVerifizierte AuflösungsdatenOrdentlich kalibriertAktuelle implizite Wahrscheinlichkeit
BPC-157 79%Führend unter 7 Optionen
Marktqualitat
41 / 100
Niedrige Qualität24h-Volumen
—
Liquidität
999,6 €
Niedrige LiquiditätSpread
4.0 pt
Mittlerer SpreadMarktdaten
Aktualisiert vor 8 Minuten
28. Juli 26, 16:30 UTC1. Okt. 27, 03:59 UTC
Trends
Verwandte Märkte
Verwandte Fragen als Kontext, kein Vergleich gleichwertiger Kontrakte.
Miami-Dade WASD ceases adding fluoride to its drinking water by 2027
Manifold MarketsHantavirus pandemic in 2026?
PolymarketMeasles cases in 2026?
KalshiWhat will Trump say during his announcement on healthcare?
KalshiHeidi Overton confirmed as FDA Commissioner by which date?
PolymarketHantavirus vaccine in 2026?
PolymarketRegeln
If the U.S. Food and Drug Administration announces publication of a proposed rule that would add BPC-157 (free base) or BPC-157 acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.
Abwicklung über:U.S. Food and Drug Administration
- If the U.S. Food and Drug Administration announces publication of a proposed rule that would add KPV (free base) or KPV acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.
- If the U.S. Food and Drug Administration announces publication of a proposed rule that would add TB-500 (free base) or TB-500 acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.
- If the U.S. Food and Drug Administration announces publication of a proposed rule that would add MOTS-c (free base) or MOTS-c acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.
- If the U.S. Food and Drug Administration announces publication of a proposed rule that would add Semax (free base) or Semax acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.
- If the U.S. Food and Drug Administration announces publication of a proposed rule that would add Epitalon (free base) or Epitalon acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.
Offene Märkte
Health & MedicineKALSHIWhat will Trump say during his announcement on healthcare?
- Favored Nation94%
- Pharma / Pharmaceutical86%
- Medicare / Medicaid85%
+23 weitere Ergebnisse
- Gesamtvolumen
- 19.848,9 €
- 24h-Volumen
- 19.822,9 €
POLYMARKETHantavirus pandemic in 2026?
- No-0.3pt97%
- Yes+0.3pt3%
- Gesamtvolumen
- 15,9 Mio. €
- 24h-Volumen
- 6522,1 €
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 4000-3.0pt93%
- Above 6000-5.0pt58%
+2 weitere Ergebnisse
- Gesamtvolumen
- 895.899,9 €
- 24h-Volumen
POLYMARKETHantavirus vaccine in 2026?
- No+0.3pt97%
- Yes-0.3pt3%
- Gesamtvolumen
- 120.707,3 €
- 24h-Volumen
- 1946,6 €
POLYMARKETMeasles cases in U.S. in 2026?
- ↑3.5k+0.7pt100%
- ↑500+0.1pt100%
- ↑1k+0.1pt100%
+9 weitere Ergebnisse
KALSHIWill the FDA approve any psychedelic substance for medical use this year?
- No65%
- Yes+13.0pt35%
- Gesamtvolumen
- 337.160,7 €
- 24h-Volumen
- 1458,9 €
- Heidi Overton confirmed as FDA Commissioner by which date?
- Measles cases in U.S. by September 30?
- How many human screwworm cases will be reported in the United States in 2026?
- When will Beam Therapeutics submit a BLA for Risto-cel?
- Which countries will report an Ebola case in 2026?
- Confirmed US Screwworm case in Livestock beyond Texas by...
- When will the FDA approve Compass Pathways' COMP360 Psilocybin?
- Ebola pandemic in 2026?
- Pandemic in 2026?
- When will the FDA reclassify BPC-157 to Category 1?
- FDA moves BPC-157 to Category 1 by which date?
Häufige Fragen
- Wie stehen die aktuellen Quoten für Which peptides will the FDA propose adding to the 503A Bulks List??
- Kalshi bewertet BPC-157 mit 79% (Stand: 18. September 2026).
- Wann wird Which peptides will the FDA propose adding to the 503A Bulks List? entschieden?
- Which peptides will the FDA propose adding to the 503A Bulks List? soll am 1. Oktober 2027 entschieden werden.
- Wie wird Which peptides will the FDA propose adding to the 503A Bulks List? abgerechnet?
- Kalshi rechnet diesen Markt wie folgt ab: If the U.S. Food and Drug Administration announces publication of a proposed rule that would add BPC-157 (free base) or BPC-157 acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.